Ajanta Pharma Limited (BOM:532331)
India
· Delayed Price · Currency is INR 2,607.30
-63.10 (-2.36%)
At close: Feb 21, 2025
Ajanta Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 325,520 | 280,899 | 154,878 | 154,667 | 155,056 | 119,225 | Upgrade
|
| Market Cap Growth | 39.58% | 81.37% | 0.14% | -0.25% | 30.05% | 30.84% | Upgrade
|
| Enterprise Value | 318,429 | 276,473 | 149,016 | 149,244 | 150,485 | 116,768 | Upgrade
|
| Last Close Price | 2607.30 | 2217.95 | 1167.06 | 1157.81 | 1142.64 | 865.20 | Upgrade
|
| PE Ratio | 36.26 | 34.42 | 26.34 | 21.70 | 23.71 | 25.49 | Upgrade
|
| PS Ratio | 8.08 | 6.67 | 4.14 | 4.63 | 5.37 | 4.61 | Upgrade
|
| PB Ratio | 9.96 | 7.87 | 4.57 | 4.74 | 5.18 | 4.59 | Upgrade
|
| P/TBV Ratio | 10.00 | 7.91 | 4.58 | 4.75 | 5.19 | 4.61 | Upgrade
|
| P/FCF Ratio | - | 44.40 | 25.08 | 37.46 | 38.31 | 54.85 | Upgrade
|
| P/OCF Ratio | - | 35.78 | 19.55 | 27.53 | 26.91 | 26.10 | Upgrade
|
| EV/Sales Ratio | 7.03 | 6.57 | 3.98 | 4.47 | 5.21 | 4.51 | Upgrade
|
| EV/EBITDA Ratio | 25.32 | 23.76 | 18.74 | 16.27 | 15.22 | 17.50 | Upgrade
|
| EV/EBIT Ratio | 28.30 | 26.44 | 21.92 | 18.47 | 16.90 | 19.87 | Upgrade
|
| EV/FCF Ratio | - | 43.70 | 24.13 | 36.15 | 37.18 | 53.72 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | 0.03 | 0.03 | 0.05 | 0.04 | 0.04 | 0.12 | Upgrade
|
| Debt / FCF Ratio | - | 0.06 | 0.06 | 0.08 | 0.09 | 0.36 | Upgrade
|
| Asset Turnover | - | 0.90 | 0.86 | 0.85 | 0.81 | 0.86 | Upgrade
|
| Inventory Turnover | - | 1.36 | 1.38 | 1.14 | 1.08 | 1.48 | Upgrade
|
| Quick Ratio | - | 1.98 | 1.71 | 2.15 | 1.85 | 1.80 | Upgrade
|
| Current Ratio | - | 3.05 | 2.49 | 3.50 | 3.13 | 2.71 | Upgrade
|
| Return on Equity (ROE) | - | 23.47% | 17.68% | 22.77% | 23.38% | 19.31% | Upgrade
|
| Return on Assets (ROA) | - | 14.03% | 9.73% | 12.89% | 15.68% | 12.21% | Upgrade
|
| Return on Capital (ROIC) | 19.47% | 18.59% | 12.63% | 15.95% | 19.49% | 14.76% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 27.94% | 19.20% | 23.70% | 28.44% | 21.67% | Upgrade
|
| Earnings Yield | 2.76% | 2.91% | 3.80% | 4.61% | 4.22% | 3.92% | Upgrade
|
| FCF Yield | 2.25% | 3.99% | 2.67% | 2.61% | 1.82% | Upgrade
| |
| Dividend Yield | 2.07% | 1.62% | 0.60% | 0.55% | 0.55% | 1.00% | Upgrade
|
| Payout Ratio | 0.00% | 78.68% | 15.25% | 11.54% | 12.68% | 24.25% | Upgrade
|
| Buyback Yield / Dilution | 0.87% | 1.65% | 1.19% | 0.74% | 0.21% | 0.85% | Upgrade
|
| Total Shareholder Return | 2.94% | 3.28% | 1.79% | 1.28% | 0.76% | 1.85% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.